Almirall

Almirall is a pharmaceutical company dedicated to providing innovative drugs around the world. The aim of the company is to achieve a leading position on the dermatologic and respiratory system diseases’ markets and growth in gastroenterology and central nervous system markets. The company’s portfolio covers products developed by an own R&D unit as well as licensed as a result of cooperation with business partners. Almirall has 13 divisions located in over 70 countries around the world.

news

more

Projekty

more

27 May 2024

“Where to Settle” campaign becomes the first in Poland to win Black Pencil award

read

21 May 2024

Solski Communications for the Alpro brand

read

09 May 2024

Solski Communications for Médecins Sans Frontières

read

18 September 2023

Solski Communications for AstraZeneca

read

07 September 2023

Solski Communications again receives highest marks from clients

read

Solski Communications supported Mastercard in promoting WhenToShop service

read

Solski Communications supported the #MastercardGrazWOSP campaign again

read

Ryanair’s new routes and development in Poland – press conference

read

„More than Italian” – the LAVAZZA campaign launch

read

The great return of SMYK to 50 Krucza Street

read